Recent publications · Crossref
5 total works indexed
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
· 2019 · cited 2,663x
- Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer
· 2005 · cited 642x
- Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
· 2019 · cited 525x
- The construction of the L3 experiment
· 1990 · cited 487x
- Designed oxygen carriers from macroporous LaFeO3 supported CeO2 for chemical-looping reforming of methane
· 2017 · cited 425x
via Crossref · CC0